首页> 外文期刊>International Journal of Analytical and Bioanalytical Chemistry >Development of oral immediate release and Sustained release dosage form of Simvastatin and its Pharmacokinetic evaluation
【24h】

Development of oral immediate release and Sustained release dosage form of Simvastatin and its Pharmacokinetic evaluation

机译:辛伐他汀口服即释和缓释剂型的研制及其药代动力学评价

获取原文
       

摘要

To examine newly developed single-unit of oral sustained release dosage form Simvastatin (SS) have been prepared by the wet granulation method. The hydrophilic matrix was prepared with xanthan gum with additives MCC PH101. On the in vitro drug release was studied. The studies indicated that the drug release can be modulated by varying the concentration of the polymer and fillers. Various pharmacokinetic parameters including AUC0¨Ct, AUC0¨C?T, Cmax, Tmax, T1/2, and elimination rate constant (Kel) were determined from plasma concentration of both formulations of test (Simvastatin 0.7 mg tablets) and reference (Simvastatin 1.4 mg tablets). The extent of absorption of drug from the sustained release tablets was significantly higher than that for the marketed simvastatin tablet because of lower elimination and longer half-life. Various pharmacokinetic parameters including AUC0-t, AUC0-?T, Cmax, Tmax, T1/2, and Keliwere determined from plasma concentratio n of both Sustained and Immediate release tablets
机译:为了检验新开发的口服缓释剂型的单一单位,已通过湿法制粒法制备了辛伐他汀(SS)。用黄原胶和添加剂MCC PH101制备亲水性基质。对体外药物的释放进行了研究。研究表明,可以通过改变聚合物和填充剂的浓度来调节药物的释放。根据两种测试制剂(辛伐他汀0.7 mg片剂)和参比制剂(辛伐他汀1.4)的血浆浓度,确定各种药物动力学参数,包括AUC0Ct,AUC0Ct,Cmax,Tmax,T1 / 2和消除速率常数(Kel)。毫克片)。从持续释放片剂中吸收药物的程度明显高于市售的辛伐他汀片剂,因为消除程度较低,半衰期更长。根据缓释片和速释片的血浆浓度确定各种药代动力学参数,包括AUC0-t,AUC0-ΔT,Cmax,Tmax,T1 / 2和Keliwe

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号